Table of Contents 1 Infantile Spasms Therapeutics Market Overview 1.1 Product Overview and Scope of Infantile Spasms Therapeutics 1.2 Classification of Infantile Spasms Therapeutics by Type 1.2.1 Global Infantile Spasms Therapeutics Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global Infantile Spasms Therapeutics Revenue Market Share by Type in 2019 1.2.3 Oral 1.2.4 Injection 1.3 Global Infantile Spasms Therapeutics Market by Application 1.3.1 Overview: Global Infantile Spasms Therapeutics Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Hospital 1.3.3 Clinic 1.4 Global Infantile Spasms Therapeutics Market by Regions 1.4.1 Global Infantile Spasms Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of Infantile Spasms Therapeutics (2015-2025) 1.4.3 North America (USA, Canada and Mexico) Infantile Spasms Therapeutics Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) Infantile Spasms Therapeutics Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infantile Spasms Therapeutics Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) Infantile Spasms Therapeutics Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infantile Spasms Therapeutics Status and Prospect (2015-2025) 2 Company Profiles 2.1 Mallinckrodt 2.1.1 Mallinckrodt Details 2.1.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Mallinckrodt SWOT Analysis 2.1.4 Mallinckrodt Product and Services 2.1.5 Mallinckrodt Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.2 Retrophin 2.2.1 Retrophin Details 2.2.2 Retrophin Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Retrophin SWOT Analysis 2.2.4 Retrophin Product and Services 2.2.5 Retrophin Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.3 Orphelia Pharma 2.3.1 Orphelia Pharma Details 2.3.2 Orphelia Pharma Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Orphelia Pharma SWOT Analysis 2.3.4 Orphelia Pharma Product and Services 2.3.5 Orphelia Pharma Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.4 H. Lundbeck 2.4.1 H. Lundbeck Details 2.4.2 H. Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 H. Lundbeck SWOT Analysis 2.4.4 H. Lundbeck Product and Services 2.4.5 H. Lundbeck Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.5 Anavex Life Sciences 2.5.1 Anavex Life Sciences Details 2.5.2 Anavex Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Anavex Life Sciences SWOT Analysis 2.5.4 Anavex Life Sciences Product and Services 2.5.5 Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.6 Insys Therapeutics 2.6.1 Insys Therapeutics Details 2.6.2 Insys Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Insys Therapeutics SWOT Analysis 2.6.4 Insys Therapeutics Product and Services 2.6.5 Insys Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.7 Catalyst Pharmaceuticals 2.7.1 Catalyst Pharmaceuticals Details 2.7.2 Catalyst Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Catalyst Pharmaceuticals SWOT Analysis 2.7.4 Catalyst Pharmaceuticals Product and Services 2.7.5 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.8 Valerion Therapeutics 2.8.1 Valerion Therapeutics Details 2.8.2 Valerion Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Valerion Therapeutics SWOT Analysis 2.8.4 Valerion Therapeutics Product and Services 2.8.5 Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 2.9 GW Pharmaceuticals 2.9.1 GW Pharmaceuticals Details 2.9.2 GW Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 GW Pharmaceuticals SWOT Analysis 2.9.4 GW Pharmaceuticals Product and Services 2.9.5 GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global Infantile Spasms Therapeutics Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 Infantile Spasms Therapeutics Players Market Share 3.2.2 Top 10 Infantile Spasms Therapeutics Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global Infantile Spasms Therapeutics Revenue and Market Share by Regions 4.2 North America Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 4.3 Europe Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 4.5 South America Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 5 North America Infantile Spasms Therapeutics Revenue by Countries 5.1 North America Infantile Spasms Therapeutics Revenue by Countries (2015-2020) 5.2 USA Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 5.3 Canada Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 5.4 Mexico Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 6 Europe Infantile Spasms Therapeutics Revenue by Countries 6.1 Europe Infantile Spasms Therapeutics Revenue by Countries (2015-2020) 6.2 Germany Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 6.3 UK Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 6.4 France Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 6.5 Russia Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 6.6 Italy Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 7 Asia-Pacific Infantile Spasms Therapeutics Revenue by Countries 7.1 Asia-Pacific Infantile Spasms Therapeutics Revenue by Countries (2015-2020) 7.2 China Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 7.3 Japan Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 7.4 Korea Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 7.5 India Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 8 South America Infantile Spasms Therapeutics Revenue by Countries 8.1 South America Infantile Spasms Therapeutics Revenue by Countries (2015-2020) 8.2 Brazil Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 8.3 Argentina Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue Infantile Spasms Therapeutics by Countries 9.1 Middle East & Africa Infantile Spasms Therapeutics Revenue by Countries (2015-2020) 9.2 Saudi Arabia Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 9.3 UAE Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 9.4 Egypt Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 9.5 South Africa Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global Infantile Spasms Therapeutics Revenue and Market Share by Type (2015-2020) 10.2 Global Infantile Spasms Therapeutics Market Forecast by Type (2019-2024) 10.3 Oral Revenue Growth Rate (2015-2025) 10.4 Injection Revenue Growth Rate (2015-2025) 11 Global Infantile Spasms Therapeutics Market Segment by Application 11.1 Global Infantile Spasms Therapeutics Revenue Market Share by Application (2015-2020) 11.2 Infantile Spasms Therapeutics Market Forecast by Application (2019-2024) 11.3 Hospital Revenue Growth (2015-2020) 11.4 Clinic Revenue Growth (2015-2020) 12 Global Infantile Spasms Therapeutics Market Size Forecast (2021-2025) 12.1 Global Infantile Spasms Therapeutics Market Size Forecast (2021-2025) 12.2 Global Infantile Spasms Therapeutics Market Forecast by Regions (2021-2025) 12.3 North America Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) 12.4 Europe Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) 12.6 South America Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global Infantile Spasms Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Infantile Spasms Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Infantile Spasms Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market Infantile Spasms Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. Mallinckrodt Corporate Information, Location and Competitors Table 6. Mallinckrodt Infantile Spasms Therapeutics Major Business Table 7. Mallinckrodt Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 8. Mallinckrodt SWOT Analysis Table 9. Mallinckrodt Infantile Spasms Therapeutics Product and Solutions Table 10. Mallinckrodt Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 11. Retrophin Corporate Information, Location and Competitors Table 12. Retrophin Infantile Spasms Therapeutics Major Business Table 13. Retrophin Infantile Spasms Therapeutics Total Revenue (USD Million) (2018-2019) Table 14. Retrophin SWOT Analysis Table 15. Retrophin Infantile Spasms Therapeutics Product and Solutions Table 16. Retrophin Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 17. Orphelia Pharma Corporate Information, Location and Competitors Table 18. Orphelia Pharma Infantile Spasms Therapeutics Major Business Table 19. Orphelia Pharma Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 20. Orphelia Pharma SWOT Analysis Table 21. Orphelia Pharma Infantile Spasms Therapeutics Product and Solutions Table 22. Orphelia Pharma Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 23. H. Lundbeck Corporate Information, Location and Competitors Table 24. H. Lundbeck Infantile Spasms Therapeutics Major Business Table 25. H. Lundbeck Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 26. H. Lundbeck SWOT Analysis Table 27. H. Lundbeck Infantile Spasms Therapeutics Product and Solutions Table 28. H. Lundbeck Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 29. Anavex Life Sciences Corporate Information, Location and Competitors Table 30. Anavex Life Sciences Infantile Spasms Therapeutics Major Business Table 31. Anavex Life Sciences Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 32. Anavex Life Sciences SWOT Analysis Table 33. Anavex Life Sciences Infantile Spasms Therapeutics Product and Solutions Table 34. Anavex Life Sciences Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 35. Insys Therapeutics Corporate Information, Location and Competitors Table 36. Insys Therapeutics Infantile Spasms Therapeutics Major Business Table 37. Insys Therapeutics Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 38. Insys Therapeutics SWOT Analysis Table 39. Insys Therapeutics Infantile Spasms Therapeutics Product and Solutions Table 40. Insys Therapeutics Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 41. Catalyst Pharmaceuticals Corporate Information, Location and Competitors Table 42. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Major Business Table 43. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 44. Catalyst Pharmaceuticals SWOT Analysis Table 45. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions Table 46. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 47. Valerion Therapeutics Corporate Information, Location and Competitors Table 48. Valerion Therapeutics Infantile Spasms Therapeutics Major Business Table 49. Valerion Therapeutics Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 50. Valerion Therapeutics SWOT Analysis Table 51. Valerion Therapeutics Infantile Spasms Therapeutics Product and Solutions Table 52. Valerion Therapeutics Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 53. GW Pharmaceuticals Corporate Information, Location and Competitors Table 54. GW Pharmaceuticals Infantile Spasms Therapeutics Major Business Table 55. GW Pharmaceuticals Infantile Spasms Therapeutics Total Revenue (USD Million) (2017-2018) Table 56. GW Pharmaceuticals SWOT Analysis Table 57. GW Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions Table 58. GW Pharmaceuticals Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 59. Global Infantile Spasms Therapeutics Revenue (Million USD) by Players (2015-2020) Table 60. Global Infantile Spasms Therapeutics Revenue Share by Players (2015-2020) Table 61. Global Infantile Spasms Therapeutics Revenue (Million USD) by Regions (2015-2020) Table 62. Global Infantile Spasms Therapeutics Revenue Market Share by Regions (2015-2020) Table 63. North America Infantile Spasms Therapeutics Revenue by Countries (2015-2020) Table 64. North America Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Table 65. Europe Infantile Spasms Therapeutics Revenue (Million USD) by Countries (2015-2020) Table 66. Asia-Pacific Infantile Spasms Therapeutics Revenue (Million USD) by Countries (2015-2020) Table 67. South America Infantile Spasms Therapeutics Revenue by Countries (2015-2020) Table 68. South America Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Table 69. Middle East and Africa Infantile Spasms Therapeutics Revenue (Million USD) by Countries (2015-2020) Table 70. Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Table 71. Global Infantile Spasms Therapeutics Revenue (Million USD) by Type (2015-2020) Table 72. Global Infantile Spasms Therapeutics Revenue Share by Type (2015-2020) Table 73. Global Infantile Spasms Therapeutics Revenue Forecast by Type (2021-2025) Table 74. Global Infantile Spasms Therapeutics Revenue by Application (2015-2020) Table 75. Global Infantile Spasms Therapeutics Revenue Share by Application (2015-2020) Table 76. Global Infantile Spasms Therapeutics Revenue Forecast by Application (2021-2025) Table 77. Global Infantile Spasms Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. Infantile Spasms Therapeutics Picture Figure 2. Global Infantile Spasms Therapeutics Revenue Market Share by Type in 2019 Figure 3. Oral Picture Figure 4. Injection Picture Figure 5. Infantile Spasms Therapeutics Revenue Market Share by Application in 2019 Figure 6. Hospital Picture Figure 7. Clinic Picture Figure 8. Global Infantile Spasms Therapeutics Revenue (USD Million) and Growth Rate (2015-2025) Figure 9. North America Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 10. Europe Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 11. Asia-Pacific Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 12. South America Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 13. Middle East and Africa Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 14. Global Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate (2015-2025) Figure 15. Global Infantile Spasms Therapeutics Revenue Share by Players in 2019 Figure 16. Global Top 5 Players Infantile Spasms Therapeutics Revenue Market Share in 2019 Figure 17. Global Top 10 Players Infantile Spasms Therapeutics Revenue Market Share in 2019 Figure 18. Key Players Market Share Trend Figure 19. Global Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 20. Global Infantile Spasms Therapeutics Revenue Market Share by Regions (2015-2020) Figure 21. Global Infantile Spasms Therapeutics Revenue Market Share by Regions in 2018 Figure 22. North America Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 23. Europe Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 24. Asia-Pacific Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 25. South America Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 26. Middle East and Africa Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 27. North America Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Figure 28. North America Infantile Spasms Therapeutics Revenue Market Share by Countries in 2019 Figure 29. USA Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 30. Canada Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 31. Mexico Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 32. Europe Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Figure 33. Europe Infantile Spasms Therapeutics Revenue Market Share by Countries in 2019 Figure 34. Germany Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 35. UK Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 36. France Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 37. Russia Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 38. Italy Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 39. Asia-Pacific Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Figure 40. Asia-Pacific Infantile Spasms Therapeutics Revenue Market Share by Countries in 2019 Figure 41. China Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 42. Japan Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 43. Korea Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 44. India Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 45. Southeast Asia Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 46. South America Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Figure 47. South America Infantile Spasms Therapeutics Revenue Market Share by Countries in 2019 Figure 48. Brazil Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 49. Argentina Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 50. Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries (2015-2020) Figure 51. Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries in 2019 Figure 52. Saudi Arabia Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 53. UAE Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 54. Egypt Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 55. South Africa Infantile Spasms Therapeutics Revenue and Growth Rate (2015-2020) Figure 56. Global Infantile Spasms Therapeutics Revenue Share by Type (2015-2020) Figure 57. Global Infantile Spasms Therapeutics Revenue Share by Type in 2019 Figure 58. Global Infantile Spasms Therapeutics Market Share Forecast by Type (2021-2025) Figure 59. Global Oral Revenue Growth Rate (2015-2020) Figure 60. Global Injection Revenue Growth Rate (2015-2020) Figure 61. Global Infantile Spasms Therapeutics Revenue Share by Application (2015-2020) Figure 62. Global Infantile Spasms Therapeutics Revenue Share by Application in 2019 Figure 63. Global Infantile Spasms Therapeutics Market Share Forecast by Application (2021-2025) Figure 64. Global Hospital Revenue Growth Rate (2015-2020) Figure 65. Global Clinic Revenue Growth Rate (2015-2020) Figure 66. Global Infantile Spasms Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 67. Global Infantile Spasms Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025) Figure 68. Global Infantile Spasms Therapeutics Revenue Market Share Forecast by Regions (2021-2025) Figure 69. North America Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) Figure 70. Europe Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) Figure 71. Asia-Pacific Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) Figure 72. South America Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) Figure 73. Middle East and Africa Infantile Spasms Therapeutics Revenue Market Forecast (2021-2025) Figure 74. Sales Channel: Direct Channel vs Indirect Channel